Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCX0B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,212
Award facts
- Contract value 100% obligated
- $24,212.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $24,212.28 by the Defense Logistics Agency (DLA) for the supply of Kesimpta 20 mg/0.4 mL pen injections. The contract is firm fixed price with no set-aside designation, indicating it was competitively awarded. The ultimate completion date is December 31, 2025, with the award issued on December 30, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
The DLA Troop Support Medical IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. This delivery order for Kesimpta, a specialty pharmaceutical treatment, exemplifies the company's role in providing critical medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's performance under this IDC reflects its capability to meet federal medical procurement requirements and positions it as a key vendor within DLA's pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FCX0B?
SPE2DR26FCX0B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FCX0B worth?
The government has obligated $24,212 on SPE2DR26FCX0B.
Is contract SPE2DR26FCX0B an order under another contract?
Yes. SPE2DR26FCX0B is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCX0B competed?
The extent of competition for SPE2DR26FCX0B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award